Drugs / porcine anti-lymphocyte immunoglobulin
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06009965 | Jan 2023 → Jan 2025 | aplastic anemia | Peking Union Medical College Hospital | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | porcine anti-lymphocyte immunoglobulin | “porcine anti-lymphocyte immunoglobulin ((p-ATG) 25 mg/kg/d x 5 days” NCT06009965 ↗ |
| Known as | p-ATG | “porcine anti-lymphocyte immunoglobulin ((p-ATG) 25 mg/kg/d x 5 days” NCT06009965 ↗ |
| Modality | Protein / enzyme biologic | “porcine anti-lymphocyte immunoglobulin” NCT06009965 ↗ |